Table 2 Association between baseline characteristics of patients and 30-months survival
Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Sex | 1.231 (0.739–2.050) | 0.425 | ||
Age | 0.985 (0.970–1.001) | 0.062 | 0.987 (0.971–1.004) | 0.132 |
Ganciclovir treatment | 1.175 (0.727–1.898) | 0.511 | 1.307 (0.759–2.251) | 0.334 |
Pneumonia | 1.353 (0.543–3.369) | 0.516 | ||
ICU | 0.943 (0.566–1.570) | 0.821 | 0.656 (0.354–1.213) | 0.179 |
Mechanical ventilation | 1.367 (0.779–2.400) | 0.276 | ||
Quick SOFA | 1.326 (0.935–1.880) | 0.113 | 1.472 (1.001–2.163) | 0.049 |
CWI | 0.884 (0.689–1.135) | 0.335 | 0.904 (0.699–1.168) | 0.796 |
Hospital days > 30 days | 0.893 (0.553–1.442) | 0.644 | ||
CMV PCR > 50,000 copies/ml | 1.094 (0.648–1.848) | 0.736 | 0.926 (0.519–1.654) | 0.796 |
Progress to CMV disease | 0.377 (0.092–1.541) | 0.175 | ||
Cardiovascular event | 1.276 (0.312–5.221) | 0.734 | ||